| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.48 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.49 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.02 |